[HTML][HTML] CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y Han, S Xu, K Cheng, C Diao… - Experimental and …, 2021 - spandidos-publications.com
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
Y Han, S Xu, K Cheng, C Diao, S Liu… - Experimental and …, 2021 - go.gale.com
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y Han, S Xu, K Cheng, C Diao… - Experimental and …, 2021 - pubmed.ncbi.nlm.nih.gov
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
Y Han, S Xu, K Cheng, C Diao, S Liu… - Experimental and …, 2021 - europepmc.org
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
Y Han, S Xu, K Cheng, C Diao, S Liu… - Experimental & …, 2021 - search.ebscohost.com
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
[PDF][PDF] CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y HAN, S XU, KAI CHENG, C DIAO… - EXPERIMENTAL …, 2021 - pdfs.semanticscholar.org
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
[HTML][HTML] CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y Han, S Xu, K Cheng, C Diao, S Liu… - Experimental and …, 2021 - ncbi.nlm.nih.gov
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y Han, S Xu, K Cheng, C Diao, S Liu… - Experimental and …, 2021 - search.proquest.com
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Y HAN, S XU, KAI CHENG, C DIAO… - EXPERIMENTAL …, 2021 - ingentaconnect.com
Papillary thyroid cancer (PTHCA) accounts for~ 85% cases of thyroid cancer and exhibits
high incidence. Targeted therapy is an effective method to combat this disease; however …
high incidence. Targeted therapy is an effective method to combat this disease; however …